Clinical predictors of n2 disease in non-small cell lung cancer

Chest

Volumn 117, Issue 6, 2000, Pages 1577-1582

  Takamochi, Kazuya ^a   Nagai, Kanji ^a   Suzuki, Kenji ^b   Yoshida, Junji ^a   Ohde, Yasuhisa ^a   Nishiwaki, Yutaka ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Caminoembryonic antigen; Computed tomography; Mediastinoscopy; N2 lung cancer; Tumor size

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; IOPAMIDOL;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; PREDICTION; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0034047899     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.6.1577     Document Type: Article

References (33)

1. 1 Ginsberg RJ. Evaluation of the mediastinum by invasive techniques. Surg Clin North Am 1987; 67:1025-1035
2. 2 Coughlin M, Deslauriers J, Beaulieu M, et al. Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer. Ann Thorac Surg 1985; 40:556-560
3. 3 Van Schil PE, Van Hee RH, Schoofs EL. The value of mediastinoscopy in preoperative staging of bronchogenic carcinoma. J Thorac Cardiovasc Surg 1989; 97:240-244
4. 4 Daly BD, Mueller JD, Faling LJ, et al. N2 lung cancer: outcome in patients with false-negative computed tomographic scans of the chest. J Thorac Cardiovasc Surg 1993; 105:904-911
5. 5 Dillemans B, Deneffe G, Verschakelen J, et al. Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer: a study of 569 patients. Eur J Cardiothorac Surg 1994; 8:37-42
6. 6 Backer CL, Shields TW, Lockhart CG, et al. Selective preoperative evaluation for possible N2 disease in carcinoma of the lung. J Thorac Cardiovasc Surg 1987; 93:337-343
7. 7 Daly BD Jr, Faling LJ, Pugatch RD, et al. Computed tomography: an effective technique for mediastinal staging in lung cancer. J Thorac Cardiovasc Surg 1984; 88:486-494
8. 8 Breyer RH, Karstaedt N, Mills SA, et al. Computed tomography for evaluation of mediastinal lymph nodes in lung cancer: correlation with surgical staging. Ann Thorac Surg 1984; 38:215-220
9. 9 Glazer GM, Orringer MB, Gross BH, et al. The mediastinum in non-small cell lung cancer: CT-surgical correlation. AJR Am J Roentgenol 1984; 142:1101-1105
10. 10 Daly BD Jr, Faling LJ, Bite G, et al. Mediastinal lymph node evaluation by computed tomography in lung cancer: an analysis of 345 patients grouped by TNM staging, tumor size, and tumor location. J Thorac Cardiovasc Surg 1987; 94:664-672
11. 11 Dales RE, Stark RM, Raman S. Computed tomography to stage lung cancer: approaching a controversy using metaanalysis. Am Rev Respir Dis 1990; 141:1096-1101
12. 12 Modini C, Passariello R, Iascone C, et al. TNM staging in lung cancer: role of computed tomography. J Thorac Cardiovasc Surg 1982; 84:569-574
13. 13 Libshitz HI, McKenna RJ Jr. Mediastinal lymph node size in lung cancer. AJR Am J Roentgenol 1984; 143:715-718
14. 14 Khan A, Gersten KC, Garvey J, et al. Oblique hilar tomography, computed tomography, and mediastinoscopy for prethoracotomy staging of bronchogenic carcinoma. Radiology 1985; 156:295-298
15. 15 Martini N, Heelan R, Westcott J, et al. Comparative merits of conventional, computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma. J Thorac Cardiovasc Surg 1985; 90:639-648
16. 16 McKenna RJ Jr, Libshitz HI, Mountain CE, et al. Roentgenographic evaluation of mediastinal nodes for preoperative assessment in lung cancer. Chest 1985; 88:206-210
17. 17 Rendina EA, Bognolo DA, Mineo TC, et al. Computed tomography for the evaluation of intrathoracic invasion by lung cancer. J Thorac Cardiovasc Surg 1987; 94:57-63
18. 18 Osborne DR, Korobkin M, Ravin CE, et al. Comparison of plain radiography, conventional tomography, and computed tomography in detecting intrathoracic lymph node metastases from lung carcinoma. Radiology 1982; 142:157-161
19. 19 World Health Organization. Histological typing of lung tumours. Neoplasma 1982; 29:111-123
20. 20 Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111:1710-1717
21. 21 Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978; 76:832-839
22. 22 Goldstraw P, Mannam GC, Kaplan DK, et al. Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). J Thorac Cardiovasc Surg 1994; 107:19-28
23. 23 Faber LP, Kittle CF, Warren WH, et al. Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer. Ann Thorac Surg 1989; 47:669-677
24. 24 Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 1994; 330:153-158
25. 25 Roth JA, Atkinson EN, Fossella F, et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 1998; 21:1-6
26. 26 Gross BH, Glazer GM, Orringer MB, et al. Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance. Radiology 1988; 166:71-74
27. 27 Suzuki K, Nagai K, Yoshida J, et al. Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. J Thorac Cardiovasc Surg 1999; 117:593-598
28. 28 Asamura H, Nakayama H, Kondo H, et al. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy? J Thorac Cardiovasc Surg 1996; 111:1125-1134
29. 29 Takizawa T, Terashima M, Koike T, et al. Lymph node metastasis in small peripheral adenocarcinoma of the lung. J Thorac Cardiovasc Surg 1998; 116:276-280
30. 30 Ford CH, Stokes HJ, Newman CE. Carcinoembryonic antigen and prognosis after radical surgery for lung cancer: immunocytochemical localization and serum levels. Br J Cancer 1981; 44:145-153
31. 31 Stokes TC, Stevens JF, Long P, et al. Preoperative carcinoembryonic antigen and survival after resection of lung cancer. Br J Dis Chest 1980; 74:390-394
32. 32 Concannon JP, Dalbow MH, Hodgson SE, et al. Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinoma. Cancer 1978; 42:1477-1483
33. 33 Rubins JB, Dunitz J, Rubins HB, et al. Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer. J Thorac Cardiovasc Surg 1998; 116:412-416